# Seelos Therapeutics Inc. (SEEL)

Source: https://www.quantisnow.com/company/SEEL
Generated: 2026-11-14T11:53:51.480Z

- Ticker: SEEL
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: seelostherapeutics.com

## About

Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.

## Latest SEEL news and filings

- 2024-12-04 18:29 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-seelos-therapeutics-inc-5799956)
- 2024-11-22 13:36 UTC [SEC Form NT 10-Q filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-seelos-therapeutics-inc-5787899)
- 2024-11-22 13:35 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-financial-statements-and-5787897)
- 2024-11-15 00:32 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-seelos-therapeutics-inc-5777674)
- 2024-11-05 18:46 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-seelos-therapeutics-inc-5752905)
- 2024-10-24 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-seelos-therapeutics-inc-5737289)
- 2024-10-24 20:10 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-5737210)
- 2024-10-24 20:05 UTC [Seelos Announces Second Postponement of its Annual Meeting of Stockholders](https://www.quantisnow.com/insight/seelos-announces-second-postponement-of-its-annual-meeting-of-stockholders-5737121)
- 2024-10-15 13:15 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-notice-of-delisting-5725105)
- 2024-10-15 13:00 UTC [Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market](https://www.quantisnow.com/insight/seelos-therapeutics-announces-notice-of-delisting-from-nasdaq-and-transfer-5725068)
- 2024-10-07 10:07 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-other-events-financial-5717678)
- 2024-09-26 20:15 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-seelos-therapeutics-inc-5706000)
- 2024-09-26 20:10 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-5705965)
- 2024-09-26 20:05 UTC [Seelos Announces Postponement of its Annual Meeting of Stockholders](https://www.quantisnow.com/insight/seelos-announces-postponement-of-its-annual-meeting-of-stockholders-5705913)
- 2024-09-25 12:53 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-material-modification-to-5704297)
- 2024-09-25 12:00 UTC [Seelos Therapeutics Announces 1-for-16 Reverse Stock Split](https://www.quantisnow.com/insight/seelos-therapeutics-announces-1-for-16-reverse-stock-split-5704194)
- 2024-09-25 10:09 UTC [SEC Form S-1] [SEC Form S-1 filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-seelos-therapeutics-inc-5704030)
- 2024-09-24 20:05 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-other-events-financial-5703472)
- 2024-09-24 12:00 UTC [Public Offering] [Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD](https://www.quantisnow.com/insight/seelos-therapeutics-announces-the-signing-of-a-material-transfer-agreement-5702913)
- 2024-09-03 13:00 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5679338)
- 2024-08-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-seelos-therapeutics-inc-5671185)
- 2024-08-20 20:01 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-seelos-therapeutics-inc-5666228)
- 2024-08-16 20:02 UTC [SEC Form S-3] [SEC Form S-3 filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-seelos-therapeutics-inc-5662667)
- 2024-08-14 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-seelos-therapeutics-inc-5659058)
- 2024-08-09 20:02 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-seelos-therapeutics-inc-5652680)
- 2024-08-08 20:06 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Shareholder Director Nominations](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-shareholder-director-nominations-5650469)
- 2024-07-30 20:23 UTC [SEC Form D] [SEC Form D filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-seelos-therapeutics-inc-5633427)
- 2024-07-26 20:01 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-other-events-financial-5629775)
- 2024-07-16 20:05 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5610831)
- 2024-07-16 18:51 UTC [Market Chatter] ['MDMA Therapy Gets Support From Prominent Research Group As FDA Weighs Action' - Green Market Report](https://www.quantisnow.com/insight/mdma-therapy-gets-support-from-prominent-research-group-as-fda-5610631)
- 2024-07-12 13:15 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5605637)
- 2024-07-10 17:18 UTC [Market Insight] [Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-seastar-medical-holding-shares-are-trading-lower-by-around-5601882)
- 2024-07-10 09:34 UTC [Market Insight] [Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-vivopower-international-shares-are-trading-higher-by-around-31-5600586)
- 2024-06-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-seelos-therapeutics-inc-5577305)
- 2024-06-25 20:23 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-seelos-therapeutics-inc-5576578)
- 2024-06-14 20:06 UTC [SEC Form S-1] [SEC Form S-1 filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-seelos-therapeutics-inc-5559010)
- 2024-06-12 18:07 UTC [Market Chatter] ['Oregon's First-In-Nation Psilocybin Industry Is Struggling To Find Paying Customers A Year After Launching' - Marijuana Moment](https://www.quantisnow.com/insight/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-5553531)
- 2024-06-07 12:08 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-pre-market-session-5544095)
- 2024-06-05 20:05 UTC [SEC Form 8-K] [Seelos Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seelos-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5539367)
- 2024-05-31 20:30 UTC [SEC Form D] [SEC Form D filed by Seelos Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-seelos-therapeutics-inc-5529837)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SEEL
- Earnings history: https://www.quantisnow.com/earnings/SEEL
- Dividend history: https://www.quantisnow.com/dividends/SEEL
- Insider transactions: https://www.quantisnow.com/insiders/SEEL
- Options chain: https://www.quantisnow.com/options/SEEL
- SEC 8-K filings only: https://www.quantisnow.com/company/SEEL/8-k
- RSS and alerts for SEEL: https://www.quantisnow.com/docs/rss-feeds.md